The revised version of the vaccine, marketed as Spikevax, follows FDA guidance recommending that this year’s shots target ...

I'm a clinical academic, which is quite a rare breed of doctor, because what I'm doing, along with other clinical academics, ...

The success of these COVID-19 vaccines is remarkable and was far from guaranteed. mRNA is incredibly delicate. Enzymes in the environment and in our bodies are quick to chop mRNA into pieces ...

From my colleague Adam Feuerstein: French drug maker Sanofi is acquiring the small biotech Vigil Neuroscience for $470 ...

We recently published a list of 10 Firms Drenched in Red Today. In this article, we are going to take a look at where Moderna ...

Moderna, Inc. (NASDAQ:MRNA) made a name for itself by quickly developing an effective coronavirus vaccine when the world needed it the most. However, the stock has largely struggled since the pandemic ...

We recently published a list of These 10 Firms Just Beat the Market Today. In this article, we are going to take a look at ...

Biopharmaceutical company BioNTech has announced funding of up to £1 billion into the UK over the next 10 years. The planned investment would be one of the biggest in the history of UK life sciences, ...

A new PEARLS article in PLoS Pathogens reviews the rapid evolution and pandemic potential of emerging influenza A viruses, ...

So far, however, one part of the solution to the productivity slump has received little public attention: boosting support ...

Ribonucleic acid, also called RNA, is a molecule present in all living cells. It plays a critical role in transmitting ...

More than 3,000 GPTs are reportedly in use at Moderna, which has partnered with OpenAI. Here's how they're using the technology.